Cargando…

LMNet: Lightweight multi-scale convolutional neural network architecture for COVID-19 detection in IoMT environment()

The COVID-19 disease, initially known as SARS-CoV-2, was first reported in early December 2019 and has caused immense damage to humans globally. The most widely used clinical screening method for COVID-19 is Reverse Transcription Polymerase Chain Reaction (RT-PCR). RT-PCR uses respiratory samples fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwivedy, Vishwajeet, Shukla, Harsh Deep, Roy, Pradeep Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376345/
https://www.ncbi.nlm.nih.gov/pubmed/35990557
http://dx.doi.org/10.1016/j.compeleceng.2022.108325
Descripción
Sumario:The COVID-19 disease, initially known as SARS-CoV-2, was first reported in early December 2019 and has caused immense damage to humans globally. The most widely used clinical screening method for COVID-19 is Reverse Transcription Polymerase Chain Reaction (RT-PCR). RT-PCR uses respiratory samples for testing, because of which, this manual technique becomes complicated, laborious and time-consuming. Even though it has a low sensitivity, it carries a considerable risk for the testing medical staff. Hence, there is a need for an automated diagnosis system that can provide quick and efficient diagnosis results. This research proposed a multi-scale lightweight CNN (LMNet) architecture for COVID-19 detection. The proposed model is computationally less expensive than previously available models and requires less memory space. The performance of the proposed LMNet model ensemble with DenseNet169 and MobileNetV2 is higher than the other state-of-the-art models. The ensemble model can be integrated at the backend of the smart devices; hence it is useful for the Internet of Medical Things (IoMT) environment.